https://www.businesswire.com/news/home/20250108537646/en/Verdiva-Bio-a-New-Clinical-Stage-Cardiometabolic-Company-Launches-with-Over-410M-in-Series-A-Financing-to-Advance-Next-Generation-Therapies/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT